使用异质模组体对β-catenin/B细胞淋巴瘤9的蛋白相互作用的破坏

Peng Sang1,2,3, Jiacheng Wei4, Mingshuang Wu1

  • 1State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, School of Pharmaceutical Sciences, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou 450001, China.

概括

通过破坏β-catenin和BCL9的相互作用来抑制Wnt/β-catenin信号传递. 通过减少细胞增殖和改善血清稳定性,这些化合物具有结直肠癌治疗潜力.